Author:
Dong Zhongyi,Xia Xiang,Zhang Zizhen
Abstract
Background: Small bowel adenocarcinoma are relatively rare tumors of the digestive system. Due to the lack of specific screening methods, patients are often diagnosed at an advanced stage. At present, there is no specific surgical guidance and chemotherapy regimen for small bowel adenocarcinoma. Here, we report a rare small bowel adenocarcinoma case with mesenteric vascular embolization and microsatellite instability, in which palliative surgery combined with chemotherapy and anti-Programmed cell death protein 1(PD-1) therapy resulted in complete remission.Case Presentation: The patient was a 55-year-old man who was admitted for suspected small bowel adenocarcinoma combined with incomplete ileus, mesenteric vascular occlusion and distant metastasis. We performed palliative surgery to remove adenocarcinoma as well as relieve obstruction. Then according to the pathological and immunohistochemical results (Stage IV and microsatellite instability), we used XELOX regimen combined with anti-PD-1 therapy. In last 2 years follow up, this patient achieved complete remission.Conclusions: The possibility of small intestinal tumor should be considered in patients with mesenteric vascular obstruction. PD-1 blockade is an effective therapy for small bowel adenocarcinoma with microsatellite instability.
Funder
National Natural Science Foundation of China
Reference19 articles.
1. Cancer statistics, 2019;Siegel;CA Cancer J Clin.,2019
2. Small bowel adenocarcinoma: epidemiology, risk factors, diagnosis and treatment;Aparicio;Dig Liver Dis.,2014
3. Trends in incidence, treatment and survival of small bowel adenocarcinomas between 1999 and 2013: a population-based study in The Netherlands;Legue;Acta Oncol.,2016
4. Small bowel adenocarcinoma, version 1;Benson;J Natl Compr Canc Netw.,2019
5. Epidemiology of cancers of the small intestine: trends, risk factors, and prevention;Barsouk;Med Sci (Basel).,2019